Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,547
Closed -$2.66M 1397
2020
Q3
$2.66M Buy
5,547
+80
+1% +$39.2K 0.02% 451
2020
Q2
$2.46M Sell
5,467
-253
-4% -$113K 0.02% 464
2020
Q1
$2.51M Hold
5,720
0.01% 578
2019
Q4
$2.51M Sell
5,720
-1,109
-16% -$467K 0.01% 578
2019
Q3
$2.85M Buy
6,829
+110
+2% +$44.9K 0.01% 563
2019
Q2
$2.42M Buy
6,719
+134
+2% +$44.8K 0.01% 613
2019
Q1
$2.11M Buy
6,585
+6,170
+1,487% +$1.89M 0.01% 628
2018
Q4
$117K Buy
+415
New +$125K ﹤0.01% 1309
2018
Q3
Sell
-36
Closed -$12K 1503
2018
Q2
$12K Buy
+36
New +$11.3K ﹤0.01% 1843
2017
Q4
Sell
-23
Closed -$4K 2682
2017
Q3
$4K Buy
+23
New +$4.52K ﹤0.01% 2393
2016
Q4
Sell
-3,503
Closed -$494K 2481
2016
Q3
$494K Sell
3,503
-45
-1% -$6.26K ﹤0.01% 939
2016
Q2
$483K Buy
+3,548
New +$471K ﹤0.01% 936
2016
Q1
Sell
-40
Closed -$5K 2623
2015
Q4
$5K Buy
+40
New +$5.91K ﹤0.01% 2255

Other funds holding CHE

Glenmede Trust's CHE Position: Q4 2020 in Review

Glenmede Trust sold out of Chemed (CHE) in Q4 2020, closing a stake of 5,547 shares — an estimated $2.66M sold.

Glenmede Trust first reported a position in CHE in Q4 2015 and held it in 13 quarters. The position peaked at $2.85M in Q3 2019. 442 funds tracked by Wall St. Rank hold CHE as of Q4 2020.

  • Glenmede Trust reported no remaining Chemed position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 5,547 Chemed shares in Q4 2020, an estimated $2.66M.
  • Glenmede Trust first reported a position in Chemed in Q4 2015 and held it in 13 quarters.
  • Glenmede Trust's Chemed position peaked at $2.85M in Q3 2019.
  • 442 funds tracked by Wall St. Rank held Chemed as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.